•A decade of clinical data with vedolizumab: the past, present, and future
•The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease-related spondyloarthritis: insights from a cross-sectional study
•Choosing NSAID treatment in axial spondyloarthritis: factors guiding clinical decision-making
•Beyond Suppression: The Plasticity, Dysfunction, and Therapeutic Reprogramming of Regulatory T Cells in Inflammatory Bowel Disease
•Communicating Risk and Safety of Inflammatory Bowel Disease Therapies
